We are The Machine Learning Immunology Company
Integration is at Our Epicenter
At Seismic Therapeutic™, we believe our unique approach to applying machine learning to biologics drug discovery will create positive change in the autoimmune landscape and the lives of patients.
PipelinePlatform
Hyper-Collaboration Fuels Our Focus
Just like our approach, we are a synthesis of many things. Keenly focused and spirited, yet curious and relentless – we are open to the possibilities of the new and the uncharted. We fully believe that our impact on the drug discovery paradigm directly correlates to our willingness to embrace inclusivity and collaboration.
See what’s happening at Seismic Therapeutic™ with our latest news and events.
November 18, 2024
Seismic Therapeutic Presents New Preclinical Data for S-4321, a Next Generation PD 1:FcγRIIb-Selective Bifunctional Agonist Antibody for the Treatment of Autoimmune Disease, at ACR Convergence 2024
Read more
November 7, 2024
Seismic Therapeutic to Participate in Upcoming Investor Conferences
Read more
November 6, 2024
Seismic Therapeutic Presents Data Demonstrating Key Capabilities and Broad Utility of Its Machine Learning-enabled IMPACT Platform to Create Novel Biologic Medicines
Read more